Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin JM do Carmo, AA da Silva, PO Sessums, SH Ebaady, BR Pace, JS Rushing, MT Davis and JE Hall OBJECTIVE: We examined whether deficiency of Src homology 2 containing phosphatase (Shp2) signaling in forebrain neurons alters metabolic and cardiovascular regulation under various conditions and if it attenuates the anorexic and cardiovascular effects of leptin. We also tested whether forebrain Shp2 deficiency alters blood pressure (BP) and heart rate (HR) responses to acute stress. DESIGN: Forebrain Shp2 À / À mice were generated by crossing Shp2 flox/flox mice with CamKIIa-cre mice. At 22-24 weeks of age, the mice were instrumented for telemetry for measurement of BP, HR and body temperature (BT). Oxygen consumption (VO2), energy expenditure and motor activity were monitored by indirect calorimetry. RESULTS: Shp2/CamKIIa-cre mice were heavier (46±3 vs 32±1 g), hyperglycemic, hyperleptinemic, hyperinsulinemic and hyperphagic compared to Shp2 flox/flox control mice. Shp2/CamKIIa-cre mice exhibited reduced food intake responses to fasting/ refeeding and impaired regulation of BT when exposed to 15 and 30 1C ambient temperatures. Despite being obese and having many features of metabolic syndrome, Shp2/CamKIIa-cre mice had similar daily average BP and HR compared to Shp2 flox/flox mice (112±2 vs 113±1 mm Hg and 595±34 vs 650±40 b.p.m.), but exhibited increased BP and HR responses to cold exposure and acute air-jet stress test. Leptin's ability to reduce food intake and to raise BP were markedly attenuated in Shp2/CamKIIa-cre mice. CONCLUSION: These results suggest that forebrain Shp2 signaling regulates food intake, appetite responses to caloric deprivation and thermogenic control of body temperature during variations in ambient temperature. Deficiency of Shp2 signaling in the forebrain is associated with augmented cardiovascular responses to cold and acute stress but attenuated BP responses to leptin.
INTRODUCTION
Src homology 2 containing phosphatase (Shp2), a non-transmembrane protein tyrosine phosphatase with two Src homology domains, has been implicated as a signaling pathway for a variety of growth factors and cytokines. Shp2 signaling in the central nervous system (CNS) has been shown to contribute to the regulation of body weight. Zheng et al. 1 found that mice with Shp2 deficiency in forebrain neurons develop obesity and some of the characteristics of metabolic syndrome including hyperglycemia, hyperinsulinemia and insulin resistance, suggesting that Shp2 may play an important role in the regulation of energy balance and metabolism. Although these observations suggest a potential role for Shp2 signaling in the CNS in regulating body weight and metabolism, the mechanisms by which defective forebrain Shp 2 signaling causes obesity are still unclear and could be related to increased food intake, increased food efficiency or altered metabolic rate. Also, the role of Shp signaling in controlling appetite, metabolic rate and body weight responses to changes in ambient temperature has not, to our knowledge, been previously reported.
As Shp2 is one of the three primary pathways for leptin receptor signaling in the CNS, mainly by eliciting downstream mitogenactivated protein kinase, [2] [3] [4] [5] Shp2 deficiency may cause obesity, in part, by impairing the effects of leptin, a peptide hormone secreted by adipocytes, which normally reduces appetite and increases metabolic rate. [6] [7] [8] [9] [10] CNS Shp2 signaling may also contribute to the cardiovascular effects of leptin. We previously provided evidence that leptin may play a key role in linking excess weight gain with increased sympathetic nervous system (SNS) activity and elevated blood pressure in obesity. 8, 11, 12 However, the role of CNS Shp2 signaling in chronic cardiovascular regulation has not, to our knowledge, been previously reported.
In the present study, we used a genetic approach to produce Shp2 deficiency specifically in forebrain neurons and determined if the resulting early-onset obesity is associated with increased food efficiency, altered appetite and body weight responses to changes in ambient temperature, and if these mice have altered food responses to refeeding after prolonged fasting. We also determined if the obese phenotype in this model is accompanied by increases in blood pressure (BP) and heart rate (HR) and altered cardiovascular responses to acute stress. In addition, we examined if Shp2 deficiency in forebrain neurons attenuates the effects of leptin on food intake and BP regulation.
Our data suggest that Shp2 deficiency in forebrain neurons causes early-onset obesity due mainly to mild hyperphagia and increased food efficiency rather than reduced energy expenditure. Our results also indicate that obesity in this model is not accompanied by increased BP, measured 24 h/day, and that these mice also exhibited attenuated BP response to chronic leptin infusion, suggesting that functional Shp2 in the forebrain may be essential for obesity and hyperleptinemia to cause hypertension. Forebrain Shp2 deletion, however, was also associated with enhanced cardiovascular responses to acute stress.
MATERIALS AND METHODS
The experimental procedures and protocols follow the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center.
Animals
Male 24-to 25-week-old Shp2 flox/flox control mice (n ¼ 22) and Shp2/ CamkIIa-cre mice (n ¼ 25) with forebrain deficiency of Shp2 signaling were used in these studies. Shp2/CamkIIa-cre mice were generated by crossing CamkIIa-Cre mice (generously provided by Dr Ionanis Dragatsis, University of Tennessee Health Sciences Center) with Shp2 flox/flox mice (generously provided by Dr Gen-Sheng Feng, Burnham Institute). Homozygous mice for the Shp2 flox allele that also expressed Cre-recombinase were used as Shp2/CamkIIa-cre mice (Figure 1a ). Homozygous mice for the Shp2 flox allele that did not express Cre-recombinase were used as controls. Both strains were on the C57BL/6 background.
Specificity of Cre expression in forebrain neurons in Shp2/CamkIIa-cre mice compared to control mice has been detailed elsewhere. 1 We observed a 50% reduction in Shp2 protein content in the hypothalamus and forebrain cortex, whereas no change in Shp2 protein content was found in the brainstem of Shp2/CamkIIa-cre mice when compared with Shp2 flox/flox mice ( Figure 1b ).
Body weight and food intake measurements from weaning to adulthood
After weaning, the mice were single-housed in a controlled temperature room (23-24 1C) with a 12-h lights on/off cycle (lights on at 0600 hours).
Food and water were offered ad libitum. Daily food intake was measured between 0830-0930 hours, and body weight was measured twice a week until 23 weeks of age. The cumulative food intake was calculated as the sum of food consumed from 6 to 13 weeks of age and net cumulative food intake was calculated as the sum of the daily difference in food intake after a change in ambient temperature minus the average food intake at 23 1C. The food efficiency was calculated as the ratio of the cumulative calories consumed divided by body weight gain from 6 to 23 weeks of age.
Telemetry measurement of blood pressure (BP) and heart rate (HR) and venous catheter implantation Under isoflurane anesthesia, Shp2 flox/flox and Shp2/CamkIIa-cre mice, at 24 weeks of age, were implanted with telemetric pressure transmitter probes inserted into the left carotid artery for determination of mean arterial pressure (MAP) and HR for 24 h every day using computerized methods for data collection as previously described. 11, 12 Daily MAP and HR were obtained from the average of 24 h of recording using a sampling rate of 1000 Hz with a duration of 10 s for every 10-min period. The mice were allowed to recover for 8-10 days after the surgery before 4 consecutive days of measurements were taken.
In additional groups of Shp2 flox/flox (n ¼ 5) and Shp2/CamkIIa-cre mice (n ¼ 6), we also implanted a venous catheter into the jugular vein and tunneled it subcutaneously, exteriorizing it between the scapulae, passing through a spring and connecting to a mouse swivel mounted on the top of the metabolic cage. The venous catheter was connected through a sterile filter to a syringe pump for continuous 24 h per day saline or leptin infusion. After 8-10 days to recover from surgery and 5 days of stable baseline control measurements, leptin infusion experiments were begun.
Acute air-jet stress test
To determine whether deletion of Shp2 signaling in forebrain neurons alters the MAP and HR responses to acute stress, 2 days after stable baseline measurements of MAP and HR were obtained (described above), the mice were placed in a special cage for air-jet stress testing. Briefly, after a 2 h period for acclimatization to the cage, MAP and HR were continuously measured, using telemetry, for 30 min before the air-jet stress test was applied. The air-jet stress test consisted of 2-s pulses of air jet delivered every 5 s during 5 consecutive minutes aimed at the forehead of the mice at an approximate distance of 5 cm using a 14-gauge needle opening at the front of the tube connected to compressed air. After the 5-min air-jet stress, MAP and HR were measured for an additional 30-min recovery period. BP and HR responses during the air-jet stress and recovery period following the air-jet stress were calculated as the changes compared to the baseline period (average of the last 10 min of baseline measurements before air-jet stress was initiated). We also calculated the area under curves for MAP and HR during the air-jet stress and recovery periods using the following parameters: average change in MAP for each minute during the 5-min air-jet stress test and for each 5 min during the 30-min recovery period.
Oxygen consumption (VO2), motor activity, body temperature (BT) and food intake response to fasting/refeeding at different ambient temperatures
In separate experiments, Shp2 flox/flox (n ¼ 10) and Shp2/CamkIIa-cre mice (n ¼ 15) at 25 weeks of age were placed individually in metabolic cages in a temperature-adjustable system (CLAMS, Columbus Inst., Columbus OH) equipped with oxygen sensors to measure oxygen consumption (VO2) and receivers to measure blood pressure (BT). Ambulatory spontaneous motor activity was determined using infrared light beams mounted in the cages in X, Y and Z axes. BT was measured using telemetry probes (Respironics Mini Emitter 4000, Bend, OR, USA) implanted intraperitoneally 8 to 10 days prior to the beginning of the experiment. VO2 was measured using Zirconia oxygen sensors. VO2 and BT were measured for 2 min at every 10-min interval continuously for 24 h every day. After the mice were acclimatized to the new environment for 3 days, VO2, BT and motor activity were measured for 5 consecutive days at the control temperature of 23 1C, and then the mice were kept at 15 or 30 1C for an additional 5-day period.
To determine whether refeeding responses after prolonged fasting were affected by Shp2 deletion in forebrain neurons, the mice were subjected to a 24-h fasting followed by a 3-day period where food was available ad libitum. This fasting/refeeding protocol was performed in different groups of mice at 15, 23 and 30 1C. 
Food intake and blood pressure responses to leptin
To determine the role of Shp2 in forebrain neurons in mediating the acute effects of leptin on appetite, food intake was measured 24 h after an intraperitoneal injection of leptin (10 mg/kg) or saline vehicle (0.3 ml) at 1700 hours in additional groups of non-instrumented Shp2 flox/flox (n ¼ 6) and Shp2/CamkIIa-cre (n ¼ 5) mice at 22 weeks of age.
We also studied the effects of leptin on regulation of blood pressure, measured for 25 h by telemetry, in mice with Shp2 deficiency. In these experiments, control measurements were made for 5 days during i.v. isotonic saline vehicle infusion. Then leptin was added to the saline vehicle and infused i.v. at the rate of 2 mg kg min À 1 for 7 days in Shp2 flox/flox and Shp2/CamKa-cre mice. Leptin infusion was then stopped and posttreatment measurements were made for 5 days while only saline vehicle was infused.
Western blotting
Hypothalamus, brainstem and forebrain cortex were homogenized in lysis buffer (KPO 4 , pH 7.4), sonicated and cleared by centrifugation (3.500 g, 5 min at 4 1C). After the supernatant protein concentration was determined using the Bradford method (Bio-rad, Hercules, CA, USA), 50 mg of protein was separated in a 4-15% precast linear gradient polyacrylamide gel (Bio-Rad, CA). After being transferred to nitrocellulose membranes, blots were rinsed in PBS and blocked in Odyssey blocking buffer (LI-COR, Lincoln, NE, USA) for 1 h at room temperature, and incubated with mouse monoclonal anti-Shp2 antibody (1:2500; BD Transduction Laboratories, Franklin Lakes, NJ, USA) overnight at 4 1C. The membranes were probed with rabbit anti-b-actin (1:5,000; Abcam, Cambridge, MA, USA) as a loading control. Membranes were incubated with IR700-conjugated donkey antimouse IgG and IR800-conjugated donkey anti-rabbit (1:2,000; Rockland Immunochemicals, Inc., Gilbertsville, PA, USA). Antibody labeling was visualized using the Odyssey Infrared Scanner (LI-COR) for simultaneous detection of two fluorprobes. Fluorescence intensity analyses were performed using Odyssey software (LI-COR). Shp2 protein level was normalized to b-actin.
Analytical methods
Plasma leptin and insulin levels were measured by ELISA kit (R&D Systems (Minneapolis, MN, USA) and Crystal Chem Inc., (Wakefield, MA, USA) respectively), and plasma glucose concentrations were determined using the glucose oxidation method (Beckman glucose analyzer 2, Brea, CA, USA).
Statistical analysis
The results are expressed as mean±s.e.m. The data obtained were analyzed by paired t test or one-way ANOVA with repeated measures followed by Dunnett's post hoc test for comparison between control and experimental values within each group when appropriate. Different groups were compared by unpaired t test or two-way ANOVA followed by Bonferroni's post hoc test when appropriate. Statistical significance was accepted at a level of Po0.05.
RESULTS
Shp2 deficiency in forebrain neurons causes early-onset obesity associated with hyperphagia, increased food efficiency and features of the metabolic syndrome Shp2/CamkIIa-cre mice were significantly heavier (B60%) than Shp2 flox/flox control mice as early as 6 weeks of age and this difference persisted until 23 weeks of age when experiments were initiated (Figure 2a ). No differences in body length (nasal-anal distance) were observed between groups (10.3 ± 0.2 vs. 10.8±0.3 cm). The increased body weight in Shp2/CamkIIa-cre mice was associated with slightly higher food intake compared to lean control mice, (Figure 2b ) which was confirmed when total cumulative food intake was measured during the 18 weeks of observation ( Figure 2c ). In addition, Shp2/CamkIIa-cre mice also exhibited increased food efficiency from 6 to 23 weeks of age compared with control mice (Figure 2d ). Although cumulative food intake was significantly higher in Shp2/CamkIIa-cre mice, their hyperphagia was modest, with only small increases in food intake that were not statistically significant during some weeks from weaning until experiments began. For instance, food intake was not significantly different between groups at 23 weeks of age (Figure 2b ), while at 25 weeks of age Shp2/CamkIIa-cre mice ate significantly more than control mice (Figure 5f ). However, average food intake from weaning to 23 weeks of age was significantly increased in Shp2/CamkIIa-cre mice compared to control Shp2 flox/flox mice, as reflected by the cumulative food intake.
At 25 weeks of age, Shp2/CamkIIa-cre mice were hyperleptinemic and hyperinsulinemic and had slightly, but not significantly, higher plasma glucose levels (Figures 2e-g) .
Food intake responses to changes in ambient temperature in Shp2flox/flox and Shp2/CamKIIa-cre mice At 25 weeks of age, Shp2/CamkIIa-cre and Shp2 flox/flox mice were exposed for 5 days to cold (15 1C) or warm ambient temperatures (thermoneutral zone of 30 1C) in order to examine if Shp2 deletion in forebrain neurons alters appetite and body weight responses to changes in ambient temperature. No significant changes in body weight were observed in either group when ambient temperature was changed from 23 to 30 1C (Figure 3a ). However, body weight was significantly increased in Shp2/CamkIIa-cre but not in Shp2 flox/flox mice when ambient temperature was changed from 23 to 15 1C for 5 days (Figure 4a ). Food intake was markedly impacted by ambient temperature in Shp2/CamkIIa-cre mice while only modest changes were observed in control mice (Figures 3b and 4b ). For instance, raising ambient temperature from 23 to 30 1C reduced food intake by 40% and 18% in Shp2/ CamkIIa-cre and Shp2 flox/flox mice, respectively (Figure 3b ), leading to a greater negative net change in cumulative food intake in Shp2/CamkIIa-cre mice during the 5-day exposure period (Figure 3c ). Lowering ambient temperature from 23 to 15 1C increased food intake in Shp2/CamkIIa-cre mice by 30% compared with only 16% increase in control mice (Figure 4b) , causing a greater positive change in net cumulative food intake in Shp2/ CamkIIa-cre mice (Figure 4c ). These results indicate that Shp2 deletion in forebrain neurons enhances appetite sensitivity to variations in ambient temperature.
Oxygen consumption (VO2), motor activity and body temperature (BT) responses to changes in ambient temperature in Shp2flox/ flox and Shp2/CamKIIa-cre mice At baseline, Shp2/CamkIIa-cre mice showed slightly reduced VO 2 (2036±341 vs 2414±171 ml kg h À 1 ) and similar metabolic rate (0.011 ± 0.002 vs 0.012 ± 0.004 kcal kg h À 1 ) compared to Shp2 flox/ flox mice. BT was not significantly different between groups at baseline (36.8 ± 0.1 vs 36.6 ± 0.1 1C). To determine whether Shp2/ CamkIIa-cre mice exhibit greater sensitivity of energy balance to the effects of changes in ambient temperature, we also measured metabolic rate, BT and VO 2 at 15 and 30 1C. Exposure to thermoneutral temperature (30 1C) caused greater reductions in VO 2 and metabolic rate in Shp2/CamkIIa-cre mice than in control mice (Figures 3d and f) , while BT also increased to a greater extent (B0.5 1C) in these mice compared to controls (B0.2 1C, Figure 3e ). At 15 1C, however, the marked increases in VO 2 and metabolic rate were similar in both groups (Figures 4d and f) , while BT decreased more in Shp2/CamkIIa-cre mice than in controls (Figure 4e ). No significant changes were observed in motor activity in either group during exposure to 15 or 30 1C, compared to 23 1C ( Supplementary Figures S1A and S1B) . Collectively, these data demonstrate that deletion of Shp2 in forebrain neurons impairs regulation of body temperature and energy balance during variations in ambient temperature, especially at thermoneutral temperatures.
Shp2, appetite and blood pressure regulation JM do Carmo et al Food intake, VO2, metabolic rate, motor activity and BT responses to fasting and refeeding and food intake responses to acute leptin injection Prolonged (24 h) fasting significantly reduced VO 2 , metabolic rate and BT in Shp2/CamkIIa-cre and Shp2 flox/flox control mice at the control ambient temperature of 23 1C (Figures 5b-d) . The reduction in VO 2 , however, did not reach significance in Shp2/ CamkIIa-cre mice (Figure 5b) . Although there was a tendency for reduced body weight in both groups, the changes were not significant (Figure 5a ). In Shp2 flox/flox mice, refeeding was associated with a significant increase in food intake that returned to control values 48 h after normal access to feed was restored ( Figure 5f ); in Shp2/CamkIIa-cre mice, no initial hyperphagia was observed during refeeding after fasting (Figure 5f ). No significant changes were observed in body weight, VO 2 , metabolic rate or BT during refeeding for groups (Figures 5e and 5g -i). Acute leptin injection reduced 24 h food intake in Shp2 flox/flox mice by B32% when compared with saline vehicle injection, whereas no differences were observed between leptin and vehicle injection in Shp2/CamkIIa-cre mice (Figure 5j ). These results indicate that Shp2 signaling in forebrain neurons contributes to the acute effects of leptin to reduce appetite.
At 15 1C or thermoneutrality, fasting caused similar changes in body weight, VO 2 , metabolic rate and BT in Shp2/CamkIIa-cre and Shp2 flox/flox mice as observed at 23 1C (Supplementary Figure S2A-H) . Similar responses to refeeding were also observed at 15 1C or thermoneutral temperatures (Supplementary Figure  S3A -J).
Baseline MAP and HR, and cardiovascular responses to fasting/ refeeding, acute air-jet stress and chronic leptin infusion
To test the hypothesis that Shp2 signaling in forebrain neurons is also important for the regulation of cardiovascular function, we measured BP and HR 24 h per day using telemetry. In addition, we examined the cardiovascular response of Shp2/CamkIIa-cre and Shp2 flox/flox control mice to acute stress. We found that although baseline BP (112±2 vs 113 ± 1 mm Hg) and HR (595 ± 34 vs 650 ± 40 bpm) for Shp2/ CamkIIa-cre and Shp2 flox/flox mice, respectively, were similar (Figures 6a and b) , the BP and HR responses to acute air-jet stress were much more pronounced in Shp2/CamkIIa-cre when compared to control mice. For instance, we observed a 25% and 110% greater rise in BP and HR, respectively, in Shp2/ CamkIIa-cre mice during the 5-min air-jet stress period (Figures 6c and d) . Moreover, BP and HR quickly returned to baseline values in Shp2 flox/flox control mice during the 30-min recovery period that followed the exposure to the air-jet, whereas in Shp2/CamkIIa-cre mice BP and HR remained elevated (Figures 6c and d) .
To determine whether Shp2/CamkIIa-cre mice exhibit greater sensitivity to the effects of changes in ambient temperature and prolonged fasting (24 h) and refeeding on cardiovascular function, we measured MAP and HR at 15 1C and thermoneutrality (30 1C). Exposure to cold temperature (15 1C) caused greater increases in MAP and HR in Shp2/CamkIIa-cre mice than in control mice (Figures 6e and f) , while no significant changes were observed at thermoneutral temperature (30 1C) between groups (Figures 6e  and f) . (Figures 6g and h) . These results indicate that Shp2 signaling in forebrain neurons also plays an important role in modulating cardiovascular response to cold and to acute stress.
In Shp2 flox/flox control mice chronic leptin infusion caused a gradual and significant elevation in MAP, while in Shp2/CamkIIacre mice the effects of leptin on MAP were attenuated (Figures 6i  and j) . This suggests that Shp2 signaling in forebrain neurons also contributes, at least in part, to the effects of leptin on BP regulation.
DISCUSSION
Our studies indicate that Shp2 signaling in forebrain neurons contributes importantly to regulation of body weight, energy expenditure and cardiovascular function. In addition, we found that Shp2 deficiency in forebrain neurons impairs regulation of body temperature during changes in ambient temperature. We also found that exposure to cold temperature caused greater increases in MAP and HR in Shp2/CamkIIa-cre mice than in control mice. In addition, the acute effect of leptin on food intake was completely abolished and the chronic BP response to leptin was attenuated in mice with Shp2 deficiency in forebrain neurons.
To our knowledge, the role of CNS Shp2 signaling in controlling metabolic and cardiovascular function under normal conditions, during acute and chronic leptin infusion, and during stress stimuli (for example, fluctuations in ambient temperature, prolonged fasting, air jet stress, etc.) has not been previously reported. Here we show that Shp2 deficiency, specifically in forebrain neurons, enhances the blood pressure and heart rate responses to cold and acute air-jet stress, modulates food intake responses to caloric deprivation and impairs body temperature regulation during exposure to cold and warm temperatures. We also show that Shp2 deficiency attenuates the effects of leptin to reduce food intake and increase BP.
Mice with Shp2 deficiency in forebrain neurons were heavier after weaning compared to lean control mice, suggesting that Shp2 signaling in these neurons plays an important role in regulating body weight early in life. Our results also confirm previous reports 1 that mice with forebrain Shp2 deficiency exhibit many metabolic abnormalities, including insulin resistance and high plasma leptin levels. 1, 13 However, despite early-onset obesity and metabolic abnormalities, these mice had similar BP and HR compared to lean control littermates, suggesting that activation of Shp2 signaling in these neurons may be important in linking obesity with elevation in BP and HR.
Shp2-mitogen-activated protein kinase activation is one of the key pathways for leptin receptor signaling in the CNS 2-5 and previous studies from our lab and others have provided evidence that leptin-induced SNS activation may play a key role in Shp2, appetite and blood pressure regulation JM do Carmo et al obesity-induced hypertension. For example, chronic leptin infusion at rates that raise blood leptin to the levels comparable to those found in obesity increase BP and HR. Also, experimental animals and humans with leptin deficiency [14] [15] [16] [17] [18] or leptin receptor deletion in the entire CNS 15 have severe obesity but normal or reduced BP and SNS activity, 14, 15 suggesting that a functional leptin system is necessary for obesity to increase SNS activity and BP. Moreover, we showed that leptin-induced activation of proopiomelanocortin neurons is required for obesity and the accompanying hyperleptinemia to increase SNS activity and raise BP and HR. 11 Thus, our current observations suggest that Shp2 signaling in forebrain neurons may be a key intracellular pathway for BP and HR responses to obesity, as well as playing an important role in regulating energy balance. Shp2 deficiency in forebrain neurons is also associated with resistance to the acute effects of leptin to reduce appetite and with attenuated BP response to chronic hyperleptinemia. Determining whether these effects are mediated specifically by Shp2 signaling in proopiomelanocortin neurons or in other forebrain neurons will require further investigation. Since in this model Shp2 was probably deleted not only in leptin receptor-containing neurons but also in non leptin receptor-containing neurons it is possible that some of the phenotypes observed in these mice are caused by alterations in other signaling pathways besides leptin signaling.
Although Shp2/CamkIIa-cre mice were not hypertensive despite marked early-onset obesity, these mice showed exacerbated BP and HR responses to cold and acute air-jet stress. The mechanisms leading to augmented cardiovascular responses to this pressor stimulus, however, are still unclear. One possibility is that Shp2 signaling in forebrain neurons modulates SNS responses to external stress stimuli, and defective Shp2 levels in these neurons cause greater variations in SNS activity and BP during stress. Another possibility is that obesity may exacerbate cardiovascular responses to stress through mechanisms that are independent of Shp signaling. Separating the effects of obesity from defective Shp2 signaling in the forebrain is challenging since dietary models of obesity, for example, add other variables such as increased BP; also, prevention of obesity by pair-feeding young Shp2/CamkIIacre mice adds the chronic stress of food deprivation in animals whose brains are reset for hyperphagia. Supporting the idea that defective forebrain Shp2 signaling greatly enhances cardiovascular responses to acute stress are our previous findings that mice with obesity comparable (or even more severe) to that found in Shp2-deficient mice have attenuated rather than enhanced responses to air jet stress, the same stimulus as used in the present study. 11 Our results indicate that deletion of forebrain Shp2 signaling leads to obesity mainly because of increased food intake and food efficiency from 7 to 23 weeks of age. Zhang et al. 1 observed no differences in food consumption in young mice from postnatal days 23 to 32 and concluded that obesity was due to decreased energy expenditure, although this was not directly assessed. 1 In the present study, we found that at 23 weeks of age these mice did exhibit significant differences in food intake, but not in oxygen consumption or motor activity compared to control mice. These findings suggest that Shp2 deficiency in forebrain neurons causes obesity mainly by increasing food intake and food efficiency rather than decreasing energy expenditure. These findings are consistent with the possibility that CNS Shp2 signaling may play an important role in regulating body weight by altering food intake rather than by altering energy expenditure.
In response to changes in ambient temperature, we found significant differences in body temperature and food intake responses in Shp2/CamKIIa-cre and control mice. For instance, we found that, upon exposure to thermoneutrality, Shp2/CamKIIa-cre mice had more pronounced reduction in food intake leading to greater negative net cumulative food intake than observed in control mice. At 15 1C, Shp2/CamKIIa-cre mice exhibited more pronounced increase in food intake, resulting in higher positive net cumulative food intake compared to control mice. These results suggest that Shp2 signaling in forebrain neurons plays a role in regulating food intake responses to changes in ambient temperature.
Another important observation from our study is that Shp2/ CamKIIa-cre mice exhibited greater changes in body temperature during variations in ambient temperature, which were not associated with changes in physical activity. Thus, our data suggest an important role for Shp2 signaling in forebrain neurons in regulation of body temperature and food intake in response to changes in metabolic demand caused by varying ambient temperature.
Caloric deprivation causes increased appetite, reduced metabolic rate and decreased SNS activity to the heart, kidneys and brown adipose tissue, and decreased heart rate and blood pressure. [18] [19] [20] In the present study, we examined whether Shp2 signaling in forebrain neurons plays an important role in mediating the appetite and metabolic and cardiovascular responses to caloric deprivation. We found that mice with Shp2 deficiency in forebrain neurons had impaired food intake responses to refeeding after 24 h of fasting at 15 1C and thermoneutrality, despite significant reductions in body temperature and heat production. We also found that exposure to cold temperature caused greater increases in MAP and HR in Shp2/CamkIIa-cre mice than in control mice; however, the BP and HR responses to refeeding were similar between Shp2/CamKIIacre and control mice. Moreover, chronic leptin infusion at a rate sufficient to raise plasma leptin levels to those found in severe obesity caused a gradual increase in MAP in control mice, and this increase in MAP was attenuated in mice with Shp2 deficiency in forebrain neurons. These mice were also resistant to the acute anorexic effects of leptin. These observations suggest that Shp2 signaling in forebrain neurons is important for leptin-mediated decreases in appetite and, to a lesser extent, in mediating the actions of leptin on BP regulation. Taken together, our findings suggest that functional Shp2 signaling in forebrain neurons is required for normal metabolic responses to caloric deprivation. Although the precise mechanisms are still unknown, Zhang et al. 1 previously showed that mice with Shp2 deficiency in forebrain neurons do not exhibit the normal increase in hypothalamic neuropeptide Y levels, an orexigenic factor important in regulating feeding behavior, after a 20 h fast. Whether changes in neuropeptide Y levels alone can fully explain the lack of reactive hyperphagia to prolonged fasting in Shp2/CamkIIa-cre mice has not been determined.
In summary, we demonstrated that Shp2 deficiency in forebrain neurons leads to early-onset obesity associated with mild hyperphagia and increased food efficiency, metabolic abnormalities and impaired body temperature regulation during changes in ambient temperature. We also found that Shp2 signaling is involved in the food intake responses to refeeding and to leptin injection, and that forebrain Shp2 plays an important role in mediating the cardiovascular response to hyperleptinemia, to cold exposure, and to acute air-jet stress. Since obesity results from an imbalance between energy intake and expenditure, understanding the mechanisms that underlie regulation of energy expenditure and appetite in response to external stimuli will be important for the development of novel treatment strategies.
